Oorsprong van het eerstegraads netwerk van Guillaume Audema

EntiteitType entiteitIndustrie
Public Company Biotechnology 6

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Guillaume Audema via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Pharmaceuticals: Major

Yannick Plétan

Corporate Officer/Principal

Investment Managers

Ignacio Faus

Consultant / Advisor

SANOFI Biotechnology

Yannick Plétan

Corporate Officer/Principal

MOLOGEN AG Miscellaneous Commercial Services

Ignacio Faus

Chief Executive Officer

Pharmaceuticals: Major

Yannick Plétan

Chief Tech/Sci/R&D Officer

CROSSJECT Medical Specialties

Yannick Plétan

Director/Board Member

Indiana University College/University

Ignacio Faus

Doctorate Degree

Miscellaneous Commercial Services

Ignacio Faus

Corporate Officer/Principal

Biotechnology

Ignacio Faus

Chief Executive Officer

DEINOVE Biotechnology

Yannick Plétan

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Ignacio Faus

Director/Board Member

Wholesale Distributors

Yannick Plétan

Corporate Officer/Principal

Harvard Business School College/University

Yannick Plétan

Graduate Degree

Kellogg School of Management College/University

Ignacio Faus

Masters Business Admin

Roche SAS

Yannick Plétan

Corporate Officer/Principal

Pharmaceuticals: Major

Yannick Plétan

Chief Tech/Sci/R&D Officer

ACTICOR BIOTECH SAS Biotechnology

Yannick Plétan

Chief Tech/Sci/R&D Officer

NH THERAGUIX SAS Pharmaceuticals: Major

Yannick Plétan

Director/Board Member

ULTRace Development Partner

Yannick Plétan

Chief Executive Officer

Statistieken

Internationaal

Frankrijk 12
Verenigde Staten 5
Spanje 4
Zwitserland 2
Duitsland 2

Sectoraal

Health Technology 11
Consumer Services 5
Commercial Services 4
Finance 2
Distribution Services 2

Operationeel

Director/Board Member 11
Chief Tech/Sci/R&D Officer 5
Corporate Officer/Principal 5
Chief Executive Officer 5
Doctorate Degree 2
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU